Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists.
Bioorg Med Chem Lett
; 24(13): 2949-53, 2014 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-24835985
ABSTRACT
The G protein-coupled receptor 40 (GPR40) mediates enhancement of glucose-stimulated insulin secretion in pancreatic ß cells. The GPR40 agonist has been attracting attention as a novel insulin secretagogue with glucose dependency for the treatment of type 2 diabetes. The optimization study of compound 1 led to a potent and bioavailable GPR40 agonist 24, which showed insulin secretion and glucose lowering effects in rat OGTT. Compound 24 is a potential lead compound for a novel insulin secretagogue with a low risk of hypoglycemia.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Propionates
/
Receptors, G-Protein-Coupled
/
Drug Discovery
Limits:
Animals
/
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2014
Type:
Article
Affiliation country:
Japan